Register Now

With growing competition, pharma manufacturers must gear up to build a competitive advantage to retain their market leadership. Computer Modelling and Simulation (CM&S) provides much-needed leverage to scale up production as they move from small pilot studies to progressively larger clinical trials, then finally into large-scale production of drugs.

Pharma manufacturing systems are highly variable with each system having different levels of interdependence and variability. Simulation helps untangle the chaos and bring out data-backed solutions.

As per industry studies, some major areas where simulation aids pharma companies are:
– Improved Manufacturing Process Efficiency: 4X reduction in product cost; 9X reduction in development cost
– Improving Fidelity of Pharma Products
– Reduce Time-To-Market: 2.5X reduction in the number of change orders which eventually leads to 67% improvement in new product introduction rate
– By enabling a confluence of industry leaders and simulation experts, this event will bring out various simulation led strategies aimed at reducing cost, accurately modelling and understanding process complexities while maintaining product differentiation and improving time to market of drugs.

Key Discussion Points:
+ Importance of Innovation in Pharma Manufacturing
+ Key Challenges Encountered by Pharma Manufacturing
+ Reducing Time-to-Market in bringing New Vaccine/Drug to the Patient
+ Making Drugs/Vaccines more Affordable for Indian Population
+ Maximizing patient safety during Vaccine/Drug Roll-out

Speakers:
+ Birendra Kumar David, Director, Dr Reddy’s Laboratories
+ Thierry Marchal, Program Director for Healthcare Solutions, Ansys
+ Hemant Punekar, Healthcare Expert- India, Ansys